Literature DB >> 29097285

Serum Meteorin-like protein levels decreased in patients newly diagnosed with type 2 diabetes.

Ju Hee Lee1, Yea Eun Kang1, Ji Min Kim1, Sorim Choung2, Kyong Hye Joung1, Hyun Jin Kim1, Bon Jeong Ku3.   

Abstract

We analyzed circulating Meteorin-like (METRNL) levels in human. Serum METRNL levels were significantly lower in subjects with diabetes mellitus compared with those without diabetes. Serum METRNL was negatively correlated with the serum glucose level and insulin resistance. Metformin treatment did not increase the serum METRL levels after 12 weeks.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Insulin resistance; Meteorin-like

Mesh：

Substances：

Year:  2017        PMID： 29097285     DOI： 10.1016/j.diabres.2017.10.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN： 0168-8227            Impact factor:   5.602


  15 in total

Review 1.  The Role of Exercise in the Interplay between Myokines, Hepatokines, Osteokines, Adipokines, and Modulation of Inflammation for Energy Substrate Redistribution and Fat Mass Loss: A Review.

Authors:  Adrian M Gonzalez-Gil; Leticia Elizondo-Montemayor
Journal:  Nutrients       Date:  2020-06-26       Impact factor: 5.717

2.  Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines.

Authors:  Maryam Dadmanesh; Hassan Aghajani; Reza Fadaei; Khodayar Ghorban
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

Review 3.  Inter-organ communication: a gatekeeper for metabolic health.

Authors:  Judit Castillo-Armengol; Lluis Fajas; Isabel C Lopez-Mejia
Journal:  EMBO Rep       Date:  2019-08-19       Impact factor: 8.807

4.  Serum Metrnl is associated with the presence and severity of coronary artery disease.

Authors:  Zheng-Xia Liu; Hui-Hong Ji; Min-Peng Yao; Li Wang; Yue Wang; Ping Zhou; Ying Liu; Xi-Feng Zheng; Hui-Wei He; Lian-Sheng Wang; Wei Gao; Xiang Lu
Journal:  J Cell Mol Med       Date:  2018-11-05       Impact factor: 5.310

5.  Increased Expression of Meteorin-Like Hormone in Type 2 Diabetes and Obesity and Its Association with Irisin.

Authors:  Irina AlKhairi; Preethi Cherian; Mohamed Abu-Farha; Ashraf Al Madhoun; Rasheeba Nizam; Motasem Melhem; Mohamed Jamal; Suleiman Al-Sabah; Hamad Ali; Jaakko Tuomilehto; Fahd Al-Mulla; Jehad Abubaker
Journal:  Cells       Date:  2019-10-19       Impact factor: 6.600

6.  Serum Metrnl Level is Correlated with Insulin Resistance, But Not with β-Cell Function in Type 2 Diabetics.

Authors:  Chuan Wang; Youjin Pan; Jia Song; Yu Sun; Hongkai Li; Li Chen; Xinguo Hou
Journal:  Med Sci Monit       Date:  2019-11-25

7.  Meteorin-like/Meteorin-β protects heart against cardiac dysfunction.

Authors:  Celia Rupérez; Gemma Ferrer-Curriu; Aina Cervera-Barea; Laura Florit; Mariona Guitart-Mampel; Gloria Garrabou; Mònica Zamora; Fàtima Crispi; Joaquim Fernandez-Solà; Josep Lupón; Antoni Bayes-Genis; Francesc Villarroya; Anna Planavila
Journal:  J Exp Med       Date:  2021-05-03       Impact factor: 14.307

8.  Meteorin-Like Ameliorates β Cell Function by Inhibiting β Cell Apoptosis of and Promoting β Cell Proliferation via Activating the WNT/β-Catenin Pathway.

Authors:  Wenchao Hu; Rui Wang; Bei Sun
Journal:  Front Pharmacol       Date:  2021-03-17       Impact factor: 5.810

9.  Circulating levels of Meteorin-like protein in polycystic ovary syndrome: A case-control study.

Authors:  Fatima Zahraa Fouani; Reza Fadaei; Nariman Moradi; Zahra Zandieh; Soheila Ansaripour; Mir Saeed Yekaninejad; Akram Vatannejad; Maryam Mahmoudi
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

Review 10.  Adipokines and Inflammation: Focus on Cardiovascular Diseases.

Authors:  Sandra Feijóo-Bandín; Alana Aragón-Herrera; Sandra Moraña-Fernández; Laura Anido-Varela; Estefanía Tarazón; Esther Roselló-Lletí; Manuel Portolés; Isabel Moscoso; Oreste Gualillo; José Ramón González-Juanatey; Francisca Lago
Journal:  Int J Mol Sci       Date:  2020-10-18       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.